Literature DB >> 16207262

Histiocytosis and bone: experience from one major Sydney teaching hospital.

N Geevasinga1, R Jeremy, C M Crombie, N Manolios.   

Abstract

Langerhans cell histiocytosis (LCH) has diverse presentations which can bring it before all physicians regardless of specialty. A retrospective audit was undertaken at Westmead Hospital, Sydney, Australia, to ascertain the incidence, epidemiology and clinical features of patients with LCH over a 10-year period (1994-2004). A total of 12 patients was identified (six male, six female). Eleven patients had involvement of the skeletal system, three of the patients had pulmonary LCH and only one patient presented with soft tissue involvement (nose and antrum). Three patients had diabetes insipidus. Our results are consistent with that noted in the published literature and confirm the low incidence, diverse nature of presentation and the differing treatment strategies available for this rare and yet interesting condition.

Entities:  

Mesh:

Year:  2005        PMID: 16207262     DOI: 10.1111/j.1445-5994.2005.00907.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  Thigh pain in a 53-year-old woman.

Authors:  Joseph J King; J Stuart Melvin; O Hans Iwenofu; Edward J Fox
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

2.  CT-guided corticosteroid injection for solitary eosinophilic granuloma of the spine.

Authors:  Eugenio Rimondi; Andreas F Mavrogenis; Giuseppe Rossi; Giuseppe Ussia; Andrea Angelini; Pietro Ruggieri
Journal:  Skeletal Radiol       Date:  2010-10-08       Impact factor: 2.199

3.  A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy.

Authors:  Takahiro Suzuki; Koji Izutsu; Shinichi Kako; Satoshi Ohta; Akira Hangaishi; Yoshinobu Kanda; Toru Motokura; Shigeru Chiba; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.